Trial Details
COMPLETEDBasic Information
| Clinical ID | c3814 |
|---|---|
| Identifier | NCT01493960 |
| Trial Title | The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Cobitolimod|DRUG: Placebo |
Participant Information
| Sponsor | InDex Pharmaceuticals |
|---|---|
| City | Hradec Králové |
| Country/Region | Czechia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2011-12 |
|---|---|
| Primary Completion Date | 2013-06 |
| Completion Date | 2014-03 |